SMPD1 and amyotrophic lateral sclerosis: Elevated acid sphingomyelinase (aSMase) levels, by degrading SM, suggest disease onset or progression of neurological disorders, including major depression, ischemic stroke, amyotrophic lateral sclerosis, multiple sclerosis, and some neurodegenerative diseases such as Alzheimer’s disease [6].